Coronavirus company news summary – Eurobio Scientific launches Covid-19 test – Liberate Medical chooses MedCrypt’s API to secure respiratory muscle stimulators

23 September 2020 (Last Updated September 23rd, 2020 09:35)

DetectaChem, a provider of portable threat detection solutions, has announced that its MD-Bio (MobileDetect Bio) BCP19 Test Pouch for Covid-19 detection successfully passed the initial Deep Dive phase in July and is advancing through Phase 1 of the NIH (National Institutes of Health) RADxSM (Rapid Acceleration of Diagnostics) Tech initiative.

French in-vitro medical diagnostics and life sciences organisation Eurobio Scientific has launched a rapid diagnostic test to detect the SARS CoV-2 virus antigen. The Sofia SARS Antigen, developed by its US partner Quidel, is complementary to PCR tests that remain the performance gold standard with regard to detection of the coronavirus. Already CE marked, it is now available for sale.

Liberate Medical has selected MedCrypt’s API to help secure its VentFree Respiratory Muscle Stimulator, a medical device that may cut down the number of days adult patients need mechanical ventilation, including patients with Covid-19. Liberate Medical secured an emergency use authorization from the US FDA for its VentFree Respiratory Muscle Stimulator in May, enabling an early launch into the market.

Atomo Diagnostics has signed an agreement with PinkTech Design Private (DIVOC) to roll out its Covid-19 antibody test in India. On non-exclusive basis, DIVOC will distribute the AtomoRapid Covid-19 test to government and corporate entities besides home-visit network in the country.